Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.06.2021 | Case report

Acetylcysteine/phytomenadione/ulipristal

Drug-induced liver injury, exanthematous drug reaction and lack of drug efficacy: 9 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kang S, et al. An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids. Drug Safety 43: 1267-1276, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1007/s40264-020-00960-1 Kang S, et al. An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids. Drug Safety 43: 1267-1276, No. 12, Dec 2020. Available from: URL: http://​doi.​org/​10.​1007/​s40264-020-00960-1
Metadaten
Titel
Acetylcysteine/phytomenadione/ulipristal
Drug-induced liver injury, exanthematous drug reaction and lack of drug efficacy: 9 case reports
Publikationsdatum
01.06.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-97817-0

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Ibrutinib

Case report

Multiple drugs

Case report

Amiodarone

Case report

Iodixanol